Skip to content

Clinical trials

Myeloproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: United States Clear all

483 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200018
200114
200221
200316
200419
200523
200625
200725
200826
200913
201017
201111
201210
201310
201410
201512
20168
201713
201814
201917
202018
202119
202216
202311
202413
202511
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed289
Terminated82
Recruiting52
Active, not recruiting34
Withdrawn12
Unknown status6
Not yet recruiting5
No longer available1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center44
National Cancer Institute (NCI)26
Incyte Corporation24
Memorial Sloan Kettering Cancer Center20
City of Hope Medical Center19
Case Comprehensive Cancer Center18
M.D. Anderson Cancer Center18
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins17
Masonic Cancer Center, University of Minnesota10
OHSU Knight Cancer Institute10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders483
Myelodysplastic Syndromes286
Leukemia, Myeloid, Acute263
Precursor Cell Lymphoblastic Leukemia-Lymphoma228
Primary Myelofibrosis226
Leukemia210
Leukemia, Lymphocytic, Chronic, B-Cell197
Leukemia, Myelomonocytic, Chronic194
Lymphoma, Non-Hodgkin187
Multiple Myeloma187

Trials

Showing 1 to 25 of 483. Each trial links to its page on Pharma Observatory.

383 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.